Market LIVE
Published markets; coverage varies by country
Product profile · United States

AZSTARYS

 ·  Patent Litigation & Settlement History ↓

IngredientDEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE
Application typeNDA
Application212994
Product003
Dosage formCAPSULE
RouteORAL
StrengthEQ 10.4MG BASE;EQ 52.3MG BASE
Approval date2021-05-07
Marketing statusPrescription
Status event—
ApplicantCOMMAVE SUB
Product source

Current GenericRadar decision

Year2037
SelectionCANDIDATE
ReviewFINAL
Anchor typeTRUE_DS_PATENT
Anchor date2037-12-09
Patent anchor2037-12-09
Exclusivity anchor2026-05-07
Protection date2037-12-09
First Final ANDA—
Status event—

ANCHOR_NO_TAIL; US:NDA:212994:003; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
90799282035-05-07DP —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
90799282035-05-07ORANGE_BOOK —NNDP
English description not available.
———
105841122037-12-09DS/DP —YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
105841122037-12-09ORANGE_BOOK —YNTRUE_DS
English description not available.
———
105841132037-12-09DP —NYU
| B1C03 issued-claim review2026-10-15: U
———
105841132037-12-09ORANGE_BOOK —NYU
English description not available.
———
107597782037-12-09DP —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
107597782037-12-09ORANGE_BOOK —NNDP
English description not available.
———
108583412037-12-09U U-3094NYU
| B1C03 issued-claim review2026-10-15: U
———
108583412037-12-09ORANGE_BOOK U-3094NYU
English description not available.
———
109542132037-12-09U U-3094NYU
| B1C03 issued-claim review2026-10-15: U
———
109542132037-12-09ORANGE_BOOK U-3094NYU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2021-05-072026-05-07English description not available.YY2026-05-07—Source
NCE2021-05-072026-05-07English description not available.YY2026-05-07
NCE
Full coverage date: 2026-05-07
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (8)
TypeDateRoleBasisSource
PATENT2035-05-07HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-12-09CANONICAL_ANCHOREnglish description not available.Source
PATENT2037-12-09CANONICAL_ANCHOREnglish description not available.Source
PATENT2037-12-09HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-12-09CANONICAL_ANCHOREnglish description not available.Source
PATENT2037-12-09CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2037-12-09CANONICAL_DECISIONANCHOR_NO_TAIL; US:NDA:212994:003; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.